My Personal CFO LLC’s Colgate-Palmolive CL Stock Holding History

My Personal CFO LLC’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-154	Closed	-$12.1K	–	205
2022 Q4	$12.1K	Buy	+154	New	+$11.5K	0.01%	241

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

My Personal CFO LLC's CL Position: Q1 2023 in Review

My Personal CFO LLC sold out of Colgate-Palmolive (CL) in Q1 2023, closing a stake of 154 shares — an estimated $12.1K sold.

My Personal CFO LLC first reported a position in CL in Q4 2022 and held it in 1 quarter. The position peaked at $12.1K in Q4 2022. 1,657 funds tracked by Wall St. Rank hold CL as of Q1 2023.

My Personal CFO LLC reported no remaining Colgate-Palmolive position as of Q1 2023 after selling out during the quarter.
My Personal CFO LLC sold 154 Colgate-Palmolive shares in Q1 2023, an estimated $12.1K.
My Personal CFO LLC first reported a position in Colgate-Palmolive in Q4 2022 and held it in 1 quarter.
My Personal CFO LLC's Colgate-Palmolive position peaked at $12.1K in Q4 2022.
1,657 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2023.

Based on My Personal CFO LLC's 13F filing for Q1 2023, filed 21 Apr 2023.